Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses

Details for Australian Patent Application No. 2011225044 (hide)

Owner Celltrion, Inc.

Inventors Shin Jae, Chang; Jong Mook, Kim; Kye Sook, Yi; Hyun Joo, Lee

Agent Madderns

Pub. Number AU-A-2011225044

PCT Pub. Number WO2011/111966

Priority 10-2010-0020587 08.03.10 KR

Filing date 7 March 2011

Wipo publication date 15 September 2011

International Classifications

C07K 16/10 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/44 Mutation or genetic engineering

C12N 15/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/111966 Priority application(s): WO2011/111966

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011225054-Text input method in portable device and portable device supporting the same

2011224995-Method and apparatus for transmitting uplink control information in a wireless communication system